Clinical Trial Update: hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a hiPSC-derived cardiomyocyte-loaded chitosan patch being studied for severe chronic ischemic heart disease in Phase 1/2, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• hiPSC-CMs-loaded Chitosan Patch

Snippet

Sponsor: HELP Therapeutics Co., Ltd. | Conditions: Ischemic Heart Failure, CABG-patients | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING